Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Venous Thrombosis

Free Subscription Articles published in PLoS One Retrieve available abstracts of 93 articles: HTML format Text format

Single Articles

January 2018
1. 
   Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
   PLoS One. 2018;13:e0191454.
   PubMed     Text format     Abstract available
   
   
   
2. HONG J, Lee JH, Yhim HY, Choi WI, et al
   Incidence of venous thromboembolism in Korea from 2009 to 2013.
   PLoS One. 2018;13:e0191897.
   PubMed     Text format     Abstract available
   
   
   
3. CHEN Y, Deng X, Shan X, Xing Y, et al
   Study of helical flow inducers with different thread pitches and diameters in vena cava.
   PLoS One. 2018;13:e0190609.
   PubMed     Text format     Abstract available
   
   
   
4. JIMENEZ-ALCAZAR M, Limacher A, Panda R, Mean M, et al
   Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism.
   PLoS One. 2018;13:e0191150.
   PubMed     Text format     Abstract available
   
   
   
5. EPSTEIN D, Berger G, Barda N, Marcusohn E, et al
   The incidence of acute pulmonary embolism following syncope in anticoagulant-naive patients: A retrospective cohort study.
   PLoS One. 2018;13:e0193725.
   PubMed     Text format     Abstract available
   
   
   
6. JARA-PALOMARES L, Otero R, Jimenez D, Praena-Fernandez JM, et al
   Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism.
   PLoS One. 2018;13:e0194673.
   PubMed     Text format     Abstract available
   
   
   
7. HANSEN PW, Sehested TSG, Fosbol EL, Torp-Pedersen C, et al
   Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011.
   PLoS One. 2018;13:e0194295.
   PubMed     Text format     Abstract available
   
   
   
8. EICHINGER S, Eischer L, Sinkovec H, Wittgruber G, et al
   Risk of venous thromboembolism during rehabilitation of patients with spinal cord injury.
   PLoS One. 2018;13:e0193735.
   PubMed     Text format     Abstract available
   
   
   
9. 
   Retraction: Percutaneous Aspiration Thrombectomy for Arterial Thromboembolism during Infrainguinal Endovascular Recanalization.
   PLoS One. 2018;13:e0196768.
   PubMed     Text format    
   
   
   
10. HERAUDEAU A, Delluc A, Le Henaff M, Lacut K, et al
    Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.
    PLoS One. 2018;13:e0194973.
    PubMed     Text format     Abstract available
    
    
    
11. KHIRFAN G, Tejwani V, Wang X, Li M, et al
    Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2018;13:e0197700.
    PubMed     Text format     Abstract available
    
    
    January 2017
12. KONIGSBRUGGE O, Posch F, Antlanger M, Kovarik J, et al
    Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
    PLoS One. 2017;12:e0169400.
    PubMed     Text format     Abstract available
    
    
    
13. PERNOD G, Caterino J, Maignan M, Tissier C, et al
    D-Dimer Use and Pulmonary Embolism Diagnosis in Emergency Units: Why Is There Such a Difference in Pulmonary Embolism Prevalence between the United States of America and Countries Outside USA?
    PLoS One. 2017;12:e0169268.
    PubMed     Text format     Abstract available
    
    
    
14. NAM KW, Kim CK, Kim TJ, An SJ, et al
    Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.
    PLoS One. 2017;12:e0172793.
    PubMed     Text format     Abstract available
    
    
    
15. BEZAN A, Posch F, Ploner F, Bauernhofer T, et al
    Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
    PLoS One. 2017;12:e0176283.
    PubMed     Text format     Abstract available
    
    
    
16. YHIM HY, Lee J, Lee JY, Lee JO, et al
    Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    PLoS One. 2017;12:e0178214.
    PubMed     Text format     Abstract available
    
    
    
17. ROBIN P, Le Roux PY, Lacut K, Planquette B, et al
    Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.
    PLoS One. 2017;12:e0178849.
    PubMed     Text format     Abstract available
    
    
    
18. MEAN M, Tritschler T, Limacher A, Breault S, et al
    Association between computed tomography obstruction index and mortality in elderly patients with acute pulmonary embolism: A prospective validation study.
    PLoS One. 2017;12:e0179224.
    PubMed     Text format     Abstract available
    
    
    
19. LEE FY, Chen WK, Chiu CH, Lin CL, et al
    Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with aortic aneurysms: A nationwide cohort study.
    PLoS One. 2017;12:e0178587.
    PubMed     Text format     Abstract available
    
    
    
20. LAU JK, Chow V, Brown A, Kritharides L, et al
    Predicting in-hospital death during acute presentation with pulmonary embolism to facilitate early discharge and outpatient management.
    PLoS One. 2017;12:e0179755.
    PubMed     Text format     Abstract available
    
    
    
21. TORTOSA C, Cabrera-Marante O, Serrano M, Martinez-Flores JA, et al
    Incidence of thromboembolic events in asymptomatic carriers of IgA anti ss2 glycoprotein-I antibodies.
    PLoS One. 2017;12:e0178889.
    PubMed     Text format     Abstract available
    
    
    
22. HASEGAWA S, Matsui T, Hane Y, Abe J, et al
    Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
    PLoS One. 2017;12:e0182045.
    PubMed     Text format     Abstract available
    
    
    
23. ZHANG Q, Wang D, Zhang M, Zhao Y, et al
    Studies on New Activities of Enantiomers of 2-(2-Hydroxypropanamido) Benzoic Acid: Antiplatelet Aggregation and Antithrombosis.
    PLoS One. 2017;12:e0170334.
    PubMed     Text format     Abstract available
    
    
    
24. LAU BD, Shaffer DL, Hobson DB, Yenokyan G, et al
    Effectiveness of two distinct web-based education tools for bedside nurses on medication administration practice for venous thromboembolism prevention: A randomized clinical trial.
    PLoS One. 2017;12:e0181664.
    PubMed     Text format     Abstract available
    
    
    
25. NAGATA N, Sakurai T, Moriyasu S, Shimbo T, et al
    Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.
    PLoS One. 2017;12:e0183423.
    PubMed     Text format     Abstract available
    
    
    
26. MOUNTAIN D, Keijzers G, Chu K, Joseph A, et al
    Correction: RESPECT-ED: Rates of Pulmonary Emboli (PE) and Sub-Segmental PE with Modern Computed Tomographic Pulmonary Angiograms in Emergency Departments: A Multi-Center Observational Study Finds Significant Yield Variation, Uncorrelated with Use or
    PLoS One. 2017;12:e0184219.
    PubMed     Text format     Abstract available
    
    
    
27. HERNANDEZ-LOPEZ R, Chavez-Gonzalez A, Torres-Barrera P, Moreno-Lorenzana D, et al
    Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction.
    PLoS One. 2017;12:e0183827.
    PubMed     Text format     Abstract available
    
    
    
28. MUELLER C, Limacher A, Mean M, Rodondi N, et al
    Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study.
    PLoS One. 2017;12:e0184868.
    PubMed     Text format     Abstract available
    
    
    
29. TASHIMA Y, Banno F, Kita T, Matsuda Y, et al
    Plasminogen Tochigi mice exhibit phenotypes similar to wild-type mice under experimental thrombotic conditions.
    PLoS One. 2017;12:e0180981.
    PubMed     Text format     Abstract available
    
    
    
30. LIPSKA-ZIETKIEWICZ BS, Gellermann J, Boyer O, Gribouval O, et al
    Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia.
    PLoS One. 2017;12:e0180926.
    PubMed     Text format     Abstract available
    
    
    
31. WANG L, Baser O, Wells P, Peacock WF, et al
    Benefit of early discharge among patients with low-risk pulmonary embolism.
    PLoS One. 2017;12:e0185022.
    PubMed     Text format     Abstract available
    
    
    
32. LEE SY, Kim EK, Kim MS, Shin SH, et al
    The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms.
    PLoS One. 2017;12:e0185785.
    PubMed     Text format     Abstract available
    
    
    
33. SUNTHARALINGAM S, Mikat C, Stenzel E, Erfanian Y, et al
    Submillisievert standard-pitch CT pulmonary angiography with ultra-low dose contrast media administration: A comparison to standard CT imaging.
    PLoS One. 2017;12:e0186694.
    PubMed     Text format     Abstract available
    
    
    
34. NAM JH, Kim DH, Yoo JH, Hwang JH, et al
    Does preoperative mechanical prophylaxis have additional effectiveness in preventing postoperative venous thromboembolism in elderly patients with hip fracture?-Retrospective case-control study.
    PLoS One. 2017;12:e0187337.
    PubMed     Text format     Abstract available
    
    
    
35. CUNHA MLR, Meijers JCM, Rosendaal FR, Vlieg AVH, et al
    Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism.
    PLoS One. 2017;12:e0187699.
    PubMed     Text format     Abstract available
    
    
    
36. BARRIOS D, Morillo R, Guerassimova I, Barbero E, et al
    Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism.
    PLoS One. 2017;12:e0187648.
    PubMed     Text format     Abstract available
    
    
    
37. ENDE-VERHAAR YM, Kroft LJM, Mos ICM, Huisman MV, et al
    Accuracy and reproducibility of CT right-to-left ventricular diameter measurement in patients with acute pulmonary embolism.
    PLoS One. 2017;12:e0188862.
    PubMed     Text format     Abstract available
    
    
    
38. LIU YY, Chiang CH, Hung SC, Chian CF, et al
    Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury.
    PLoS One. 2017;12:e0187637.
    PubMed     Text format     Abstract available
    
    
    
39. KIM ES, Baran AM, Mondo EL, Rodgers TD, et al
    Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    PLoS One. 2017;12:e0189410.
    PubMed     Text format     Abstract available
    
    
    January 2016
40. PRZYGODZKI T, Talar M, Blazejczyk A, Kalchenko V, et al
    Quantification of the Blood Platelet Reactivity in the ADP-Induced Model of Non-Lethal Pulmonary Thromboembolism in Mice with the Use of Laser Doppler Flowmetry.
    PLoS One. 2016;11:e0146346.
    PubMed     Text format     Abstract available
    
    
    
41. XI Q, Liu Z, Zhao Z, Luo Q, et al
    High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2016;11:e0147396.
    PubMed     Text format     Abstract available
    
    
    
42. GALLAGHER AM, Williams T, Leufkens HG, de Vries F, et al
    The Impact of the Choice of Data Source in Record Linkage Studies Estimating Mortality in Venous Thromboembolism.
    PLoS One. 2016;11:e0148349.
    PubMed     Text format     Abstract available
    
    
    
43. 
    Correction: Quantification of the Blood Platelet Reactivity in the ADP-Induced Model of Non-Lethal Pulmonary Thromboembolism in Mice with the Use of Laser Doppler Flowmetry.
    PLoS One. 2016;11:e0149829.
    PubMed     Text format     Abstract available
    
    
    
44. STUBBLEFIELD WB, Alves NJ, Rondina MT, Kline JA, et al
    Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism.
    PLoS One. 2016;11:e0148747.
    PubMed     Text format     Abstract available
    
    
    
45. BACH AG, Taute BM, Baasai N, Wienke A, et al
    30-Day Mortality in Acute Pulmonary Embolism: Prognostic Value of Clinical Scores and Anamnestic Features.
    PLoS One. 2016;11:e0148728.
    PubMed     Text format     Abstract available
    
    
    
46. LO GULLO A, Koster MJ, Crowson CS, Makol A, et al
    Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.
    PLoS One. 2016;11:e0149579.
    PubMed     Text format     Abstract available
    
    
    
47. STICCHI E, Magi A, Kamstrup PR, Marcucci R, et al
    Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism.
    PLoS One. 2016;11:e0149427.
    PubMed     Text format     Abstract available
    
    
    
48. NG AC, Adikari D, Yuan D, Lau JK, et al
    The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism.
    PLoS One. 2016;11:e0150448.
    PubMed     Text format     Abstract available
    
    
    
49. INSAM C, Mean M, Limacher A, Angelillo-Scherrer A, et al
    Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research Study.
    PLoS One. 2016;11:e0148348.
    PubMed     Text format     Abstract available
    
    
    
50. RICHTER MJ, Milger K, Haase S, Sommer N, et al
    The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2016;11:e0152580.
    PubMed     Text format     Abstract available
    
    
    
51. POPOOLA VO, Lau BD, Shihab HM, Farrow NE, et al
    Patient Preferences for Receiving Education on Venous Thromboembolism Prevention - A Survey of Stakeholder Organizations.
    PLoS One. 2016;11:e0152084.
    PubMed     Text format     Abstract available
    
    
    
52. JIANG J, Li W, Liang B, Xie R, et al
    A Novel Prioritization Method in Identifying Recurrent Venous Thromboembolism-Related Genes.
    PLoS One. 2016;11:e0153006.
    PubMed     Text format     Abstract available
    
    
    
53. HAN D, O Hartaigh B, Lee JH, Cho IJ, et al
    Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.
    PLoS One. 2016;11:e0153514.
    PubMed     Text format     Abstract available
    
    
    
54. ROY PM, Rachas A, Meyer G, Le Gal G, et al
    Multifaceted Intervention to Prevent Venous Thromboembolism in Patients Hospitalized for Acute Medical Illness: A Multicenter Cluster-Randomized Trial.
    PLoS One. 2016;11:e0154832.
    PubMed     Text format     Abstract available
    
    
    
55. VUILLEUMIER N, Simona A, Mean M, Limacher A, et al
    Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism.
    PLoS One. 2016;11:e0155973.
    PubMed     Text format     Abstract available
    
    
    
56. VENE N, Mavri A, Gubensek M, Tratar G, et al
    Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry.
    PLoS One. 2016;11:e0156943.
    PubMed     Text format     Abstract available
    
    
    
57. FU D, Zhao Y, Shen J, Cai Z, et al
    Comparison of Venous Thromboembolism after Total Artificial Joint Replacement between Musculoskeletal Tumors and Osteoarthritis of the Knee by a Single Surgeon.
    PLoS One. 2016;11:e0158215.
    PubMed     Text format     Abstract available
    
    
    
58. SABEL BO, Buric K, Karara N, Thierfelder KM, et al
    High-Pitch CT Pulmonary Angiography in Third Generation Dual-Source CT: Image Quality in an Unselected Patient Population.
    PLoS One. 2016;11:e0146949.
    PubMed     Text format     Abstract available
    
    
    
59. COHEN AT, Hamilton M, Bird A, Mitchell SA, et al
    Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    PLoS One. 2016;11:e0160064.
    PubMed     Text format     Abstract available
    
    
    
60. SIKKENS JJ, Beekman DG, Thijs A, Bossuyt PM, et al
    How Much Overtesting Is Needed to Safely Exclude a Diagnosis? A Different Perspective on Triage Testing Using Bayes' Theorem.
    PLoS One. 2016;11:e0150891.
    PubMed     Text format     Abstract available
    
    
    
61. POHLE S, Baty F, Brutsche M
    In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012.
    PLoS One. 2016;11:e0151940.
    PubMed     Text format     Abstract available
    
    
    
62. JOHN G, Platon A, Poletti PA, Perrier A, et al
    Contrast Circulation Time to Assess Right Ventricular Dysfunction in Pulmonary Embolism: A Retrospective Pilot Study.
    PLoS One. 2016;11:e0159674.
    PubMed     Text format     Abstract available
    
    
    
63. JUJO T, Tanabe N, Sakao S, Ishibashi-Ueda H, et al
    Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2016;11:e0161827.
    PubMed     Text format     Abstract available
    
    
    
64. HOFMANN E, Faller N, Limacher A, Mean M, et al
    Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.
    PLoS One. 2016;11:e0162108.
    PubMed     Text format     Abstract available
    
    
    
65. SMABREKKE B, Rinde LB, Hindberg K, Hald EM, et al
    Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromso Study.
    PLoS One. 2016;11:e0163242.
    PubMed     Text format     Abstract available
    
    
    
66. COHEN AT, Hamilton M, Bird A, Mitchell SA, et al
    Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    PLoS One. 2016;11:e0163386.
    PubMed     Text format     Abstract available
    
    
    
67. YEH JJ, Wang YC, Kao CH
    Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism.
    PLoS One. 2016;11:e0162483.
    PubMed     Text format     Abstract available
    
    
    
68. STEVANOVIC J, de Jong LA, Kappelhoff BS, Dvortsin EP, et al
    Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands.
    PLoS One. 2016;11:e0163550.
    PubMed     Text format     Abstract available
    
    
    
69. TANG Z, Wang X, Huang J, Zhou X, et al
    Gene Expression Profiling of Pulmonary Artery in a Rabbit Model of Pulmonary Thromboembolism.
    PLoS One. 2016;11:e0164530.
    PubMed     Text format     Abstract available
    
    
    
70. MOUNTAIN D, Keijzers G, Chu K, Joseph A, et al
    RESPECT-ED: Rates of Pulmonary Emboli (PE) and Sub-Segmental PE with Modern Computed Tomographic Pulmonary Angiograms in Emergency Departments: A Multi-Center Observational Study Finds Significant Yield Variation, Uncorrelated with Use or Small PE Rat
    PLoS One. 2016;11:e0166483.
    PubMed     Text format     Abstract available
    
    
    
71. LEE DK, Kim HJ, Lee DH
    Incidence of Deep Vein Thrombosis and Venous Thromboembolism following TKA in Rheumatoid Arthritis versus Osteoarthritis: A Meta-Analysis.
    PLoS One. 2016;11:e0166844.
    PubMed     Text format     Abstract available
    
    
    
72. BING R, Chow V, Lau JK, Thomas L, et al
    Prevalence of Echocardiography Use in Patients Hospitalized with Confirmed Acute Pulmonary Embolism: A Real-World Observational Multicenter Study.
    PLoS One. 2016;11:e0168554.
    PubMed     Text format     Abstract available
    
    
    
73. HORVEI LD, Braekkan SK, Hansen JB
    Weight Change and Risk of Venous Thromboembolism: The Tromso Study.
    PLoS One. 2016;11:e0168878.
    PubMed     Text format     Abstract available
    
    
    
74. HAI JJ, Chan PH, Chan YH, Fong CH, et al
    Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry.
    PLoS One. 2016;11:e0169095.
    PubMed     Text format     Abstract available
    
    
    
75. SINDET-PEDERSEN C, Bruun Oestergaard L, Gundlund A, Fosbol EL, et al
    Familial Clustering of Venous Thromboembolism - A Danish Nationwide Cohort Study.
    PLoS One. 2016;11:e0169055.
    PubMed     Text format     Abstract available
    
    
    January 2015
76. KOHYAMA T, Moriyama K, Kanai R, Kotani M, et al
    Accuracy of pulse oximeters in detecting hypoxemia in patients with chronic thromboembolic pulmonary hypertension.
    PLoS One. 2015;10:e0126979.
    PubMed     Text format     Abstract available
    
    
    
77. MAHE I, Sterpu R, Bertoletti L, Lopez-Jimenez L, et al
    Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
    PLoS One. 2015;10:e0128741.
    PubMed     Text format     Abstract available
    
    
    
78. JIANG L, Ma Y, Zhao C, Shen W, et al
    Role of Transthoracic Lung Ultrasonography in the Diagnosis of Pulmonary Embolism: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0129909.
    PubMed     Text format     Abstract available
    
    
    
79. MARUYAMA K, Akiyama M, Kokame K, Sekiya A, et al
    ELISA-Based Detection System for Protein S K196E Mutation, a Genetic Risk Factor for Venous Thromboembolism.
    PLoS One. 2015;10:e0133196.
    PubMed     Text format     Abstract available
    
    
    
80. DENG X, Li Y, Zhou L, Liu C, et al
    Gender Differences in the Symptoms, Signs, Disease History, Lesion Position and Pathophysiology in Patients with Pulmonary Embolism.
    PLoS One. 2015;10:e0133993.
    PubMed     Text format     Abstract available
    
    
    
81. JUJO T, Sakao S, Ishibashi-Ueda H, Ishida K, et al
    Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance.
    PLoS One. 2015;10:e0133167.
    PubMed     Text format     Abstract available
    
    
    
82. JUJO T, Sakao S, Ishibashi-Ueda H, Ishida K, et al
    Correction: Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance.
    PLoS One. 2015;10:e0138040.
    PubMed     Text format     Abstract available
    
    
    
83. TANG X, Sun B, Yang Y, Tong Z, et al
    A Survey of the Knowledge of Venous Thromboembolism Prophylaxis among the Medical Staff of Intensive Care Units in North China.
    PLoS One. 2015;10:e0139162.
    PubMed     Text format     Abstract available
    
    
    
84. WEI LM, Zhu YQ, Liu F, Zhang PL, et al
    Percutaneous Aspiration Thrombectomy for Arterial Thromboembolism during Infrainguinal Endovascular Recanalization.
    PLoS One. 2015;10:e0140494.
    PubMed     Text format     Abstract available
    
    
    
85. KOHYAMA T, Moriyama K, Kanai R, Kotani M, et al
    Correction: Accuracy of Pulse Oximeters in Detecting Hypoxemia in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2015;10:e0141944.
    PubMed     Text format     Abstract available
    
    
    
86. HAXAIRE C, Tromeur C, Couturaud F, Leroyer C, et al
    A Qualitative Study to Appraise Patients and Family Members Perceptions, Knowledge, and Attitudes towards Venous Thromboembolism Risk.
    PLoS One. 2015;10:e0142070.
    PubMed     Text format     Abstract available
    
    
    
87. MARIK PE, Cavallazzi R
    Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0143252.
    PubMed     Text format     Abstract available
    
    
    
88. COHEN AT, Hamilton M, Mitchell SA, Phatak H, et al
    Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    PLoS One. 2015;10:e0144856.
    PubMed     Text format     Abstract available
    
    
    
89. BOURAS G, Burns EM, Howell AM, Bottle A, et al
    Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England.
    PLoS One. 2015;10:e0145759.
    PubMed     Text format     Abstract available
    
    
    
90. HILL MD, Martin RH, Palesch YY, Moy CS, et al
    Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.
    PLoS One. 2015;10:e0131390.
    PubMed     Text format     Abstract available
    
    
    
91. YAMAMURA A, Ohara N, Tsukamoto K
    Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension.
    PLoS One. 2015;10:e0138384.
    PubMed     Text format     Abstract available
    
    
    January 2014
92. MOSER B, Megerle A, Bekos C, Janik S, et al
    Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH.
    PLoS One. 2014;9:e106440.
    PubMed     Text format     Abstract available
    
    
    
93. WANG F, Long G, Zhao C, Li H, et al
    Atherosclerosis-Related Circulating miRNAs as Novel and Sensitive Predictors for Acute Myocardial Infarction.
    PLoS One. 2014;9:e105734.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: